BR9707004A - Composto processo para preparar o mesmo composição farmacêutica utilização do composto e processos para tratamento de doenças do sistema endocinológico e para a manufatura de um medicamento - Google Patents
Composto processo para preparar o mesmo composição farmacêutica utilização do composto e processos para tratamento de doenças do sistema endocinológico e para a manufatura de um medicamentoInfo
- Publication number
- BR9707004A BR9707004A BR9707004A BR9707004A BR9707004A BR 9707004 A BR9707004 A BR 9707004A BR 9707004 A BR9707004 A BR 9707004A BR 9707004 A BR9707004 A BR 9707004A BR 9707004 A BR9707004 A BR 9707004A
- Authority
- BR
- Brazil
- Prior art keywords
- compound
- preparing
- endokinological
- medicine
- manufacture
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Diabetes (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Endocrinology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Pulmonology (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Psychiatry (AREA)
- Reproductive Health (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK4296 | 1996-01-17 | ||
DK24696 | 1996-03-05 | ||
DK24996 | 1996-03-05 | ||
DK24896 | 1996-03-05 | ||
DK24796 | 1996-03-05 | ||
PCT/DK1997/000018 WO1997026264A1 (en) | 1996-01-17 | 1997-01-16 | Pyrido-1,2,4-thiadiazine and pyrido-1,4-thiazine derivatives, their preparation and use |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9707004A true BR9707004A (pt) | 1999-07-20 |
Family
ID=27512741
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9707004A BR9707004A (pt) | 1996-01-17 | 1997-01-16 | Composto processo para preparar o mesmo composição farmacêutica utilização do composto e processos para tratamento de doenças do sistema endocinológico e para a manufatura de um medicamento |
Country Status (16)
Country | Link |
---|---|
US (1) | US5792764A (pt) |
EP (1) | EP0877748B1 (pt) |
JP (1) | JP2000503651A (pt) |
KR (1) | KR19990077320A (pt) |
CN (1) | CN1208418A (pt) |
AT (1) | ATE281460T1 (pt) |
AU (1) | AU727905B2 (pt) |
BR (1) | BR9707004A (pt) |
CA (1) | CA2241565A1 (pt) |
CZ (1) | CZ220598A3 (pt) |
DE (1) | DE69731458T2 (pt) |
IL (1) | IL125072A (pt) |
NO (1) | NO983285L (pt) |
PL (1) | PL327927A1 (pt) |
RU (1) | RU2193564C2 (pt) |
WO (1) | WO1997026264A1 (pt) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6329368B1 (en) * | 1997-05-09 | 2001-12-11 | The Regents Of The University Of California | Endocrine modulation with positive modulators of AMPA type glutamate receptors |
AU1663399A (en) * | 1997-12-19 | 1999-07-12 | Novo Nordisk A/S | Pyrido 1,2,4-thiadiazine derivatives, their preparation and use |
AU2001265840A1 (en) * | 2000-06-26 | 2002-01-08 | Novo-Nordisk A/S | Use of potassium channel agonists for reducing fat food comsumption |
AU2002365289A1 (en) * | 2001-11-30 | 2003-06-10 | Novo Nordisk A/S | Use of selective potassium channel openers |
US20030109519A1 (en) * | 2001-11-30 | 2003-06-12 | Jeppe Sturis | Use of selective potassium channel openers |
AU2002342600A1 (en) * | 2001-11-30 | 2003-06-10 | Novo Nordisk A/S | Use of selective potassium channel openers |
AU2003232171A1 (en) * | 2002-06-14 | 2003-12-31 | Novo Nordisk A/S | Combined use of a modulator of cd3 and a beta cell resting compound |
WO2013191984A1 (en) * | 2012-06-21 | 2013-12-27 | Boehringer Ingelheim International Gmbh | Fused thiazin-3-ones as kca3.1 inhibitors |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1368948A (en) * | 1970-11-11 | 1974-10-02 | Manuf Prod Pharma | Pyridine derivatives |
FR2703051B1 (fr) * | 1993-03-26 | 1995-04-28 | Adir | Nouvelles pyridothiadiazines, leurs procédés de préparation, et les compositions pharmaceutiques qui les contiennent. |
-
1997
- 1997-01-16 AT AT97900933T patent/ATE281460T1/de not_active IP Right Cessation
- 1997-01-16 WO PCT/DK1997/000018 patent/WO1997026264A1/en not_active Application Discontinuation
- 1997-01-16 CA CA002241565A patent/CA2241565A1/en not_active Abandoned
- 1997-01-16 RU RU98115386/04A patent/RU2193564C2/ru active
- 1997-01-16 KR KR1019980705467A patent/KR19990077320A/ko not_active Application Discontinuation
- 1997-01-16 BR BR9707004A patent/BR9707004A/pt unknown
- 1997-01-16 JP JP9525608A patent/JP2000503651A/ja not_active Ceased
- 1997-01-16 IL IL12507297A patent/IL125072A/en not_active IP Right Cessation
- 1997-01-16 PL PL97327927A patent/PL327927A1/xx unknown
- 1997-01-16 CZ CZ982205A patent/CZ220598A3/cs unknown
- 1997-01-16 CN CN97191748A patent/CN1208418A/zh active Pending
- 1997-01-16 EP EP97900933A patent/EP0877748B1/en not_active Expired - Lifetime
- 1997-01-16 AU AU14370/97A patent/AU727905B2/en not_active Ceased
- 1997-01-16 DE DE69731458T patent/DE69731458T2/de not_active Expired - Lifetime
- 1997-01-17 US US08/785,435 patent/US5792764A/en not_active Expired - Lifetime
-
1998
- 1998-07-16 NO NO983285A patent/NO983285L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
ATE281460T1 (de) | 2004-11-15 |
KR19990077320A (ko) | 1999-10-25 |
IL125072A0 (en) | 1999-01-26 |
DE69731458D1 (de) | 2004-12-09 |
EP0877748A1 (en) | 1998-11-18 |
AU727905B2 (en) | 2001-01-04 |
US5792764A (en) | 1998-08-11 |
EP0877748B1 (en) | 2004-11-03 |
CA2241565A1 (en) | 1997-07-24 |
NO983285D0 (no) | 1998-07-16 |
NO983285L (no) | 1998-09-16 |
IL125072A (en) | 2002-12-01 |
PL327927A1 (en) | 1999-01-04 |
JP2000503651A (ja) | 2000-03-28 |
AU1437097A (en) | 1997-08-11 |
RU2193564C2 (ru) | 2002-11-27 |
WO1997026264A1 (en) | 1997-07-24 |
DE69731458T2 (de) | 2005-12-22 |
CZ220598A3 (cs) | 1998-12-16 |
CN1208418A (zh) | 1999-02-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE175201T1 (de) | Mono-n-substituierte 1,4,7,10- tetraazacyclododecan-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel | |
BR9810592A (pt) | Composto, processos para preparar um composto, para tratar ou prevenir doenças do sistema endócrino e para a fabricação de um medicamento, composição farmacêutica, e, uso de um composto | |
ATE148610T1 (de) | Antimikrobielle mittel sowie substituierte 2- cyclohexan-1-yl-amin-derivate und deren herstellung | |
DE69113155T2 (de) | 17-beta-substituierte-4-aza-5-alpha-androstan-3-one-derivate und verfahren zu ihrer herstellung. | |
DE68914488T2 (de) | 2-(2-Hydroxy-3-phenoxypropylamino)ethylphenoxyacetamide, Verfahren und Zwischenprodukte zu deren Herstellung. | |
PT649846E (pt) | Derivados da galantamina processo para a sua preparacao e sua utilizacao como medicamentos | |
ATE247645T1 (de) | Neue piperazinylalkylthiopyrimidine derivate, diese enthaltende pharmazeutische zusammenstellungen und verfahren zu deren herstellung | |
DE69813565D1 (de) | Substituierte 3,3-diamino-2-propennitrile, ihre herstellung und verwendung | |
BR9707004A (pt) | Composto processo para preparar o mesmo composição farmacêutica utilização do composto e processos para tratamento de doenças do sistema endocinológico e para a manufatura de um medicamento | |
ATE66913T1 (de) | Amidverbindungen, verfahren zu ihrer herstellung und zusammensetzung zur aktivierung gastromotorischer funktionen. | |
AU1027992A (en) | Substituted 1,2,3,4-tetrahydrocyclopent(b)indoles, 1,2,3,3a,4,8a-hexahydrocyclopent(b)indoles and related compounds, intermediates and a process for the preparation thereof and their use as medicaments | |
ATE172976T1 (de) | 3-aminochroman-spiroderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen | |
ATE267832T1 (de) | Substanz gm-95, verfahren zu ihrer herstellung und ihre verwendung | |
ATE170520T1 (de) | Eburnan-derivate, verfahren zur ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen | |
ATE270287T1 (de) | 2,3-dihydro-1h-isoindolderivate, verfahren zu ihrer herstellung und ihre verwendung als hemmer der serotoninwiederaufnahme | |
DE69619868D1 (de) | Piperazinylalkylthiopyrimidin derivate, diese enthaltende pharmazeutische zusammensetzungen und verfahren zu deren herstellung | |
ATE100102T1 (de) | Substituierte derivate von 20,21dinoreburnamenin, verfahren zur herstellung und so hergestellte zwischenprodukte, ihre verwendung als arzneimittel und diese enthaltende pharmazeutische zusammenstellungen. | |
MA21913A1 (fr) | Procede de preparation de derives amino-oligohydroxy inhibiteurs de la renine . | |
DK0521766T3 (da) | Hidtil ukendt fremgangsmåde til syntese af enantiomerer af 3-aminochromanderivater | |
ATE140216T1 (de) | (cyclohexyl)alkenderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen | |
ATE152710T1 (de) | (thia)cycloalkyl(b)indole, verfahren zu ihrer herstellung und diese enthaltende zusammensetzungen | |
HUT57746A (en) | Process for producing new 1,3-oxazines and pharmaceutical compositions comprising same | |
AU1621392A (en) | New 1-amidooctahydropyrido(2,1-c)(1,4)oxazine compounds, processes for preparing these and pharmaceutical compositions containing them | |
UA66755C2 (en) | Derivatives of condensed 1,2,4-thiadiazine, a method for the preparation thereof, pharmaceutical composition and a method for treatment or prevention of endocrine system diseases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |